These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 15536019

  • 21. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K, Reese CE, Mason MP, Beaird LC, Tudor-Locke C, Vaughan LA.
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [Abstract] [Full Text] [Related]

  • 22. Postprandial changes in LDL phenotypes in patients with myocardial infarction.
    Koba S, Tsunoda F, Hirano T, Iso Y, Suzuki H, Geshi E, Katagiri T.
    Eur J Clin Invest; 2005 Mar; 35(3):171-9. PubMed ID: 15733071
    [Abstract] [Full Text] [Related]

  • 23. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG, Ishisaka DY, Luo D, Ntanios F, Wun CC.
    Am J Cardiol; 2007 Aug 01; 100(3):445-9. PubMed ID: 17659926
    [Abstract] [Full Text] [Related]

  • 24. Relationship of low-density lipoprotein (LDL) particle size to thyroid function status in Koreans.
    Kim CS, Kang JG, Lee SJ, Ihm SH, Yoo HJ, Nam JS, Ahn CW, Kim KR.
    Clin Endocrinol (Oxf); 2009 Jul 01; 71(1):130-6. PubMed ID: 19178521
    [Abstract] [Full Text] [Related]

  • 25. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 01; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 26. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
    Wolffenbuttel BH, Franken AA, Vincent HH, Dutch Corall Study Group.
    J Intern Med; 2005 Jun 01; 257(6):531-9. PubMed ID: 15910557
    [Abstract] [Full Text] [Related]

  • 27. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.
    Metabolism; 2006 Jul 01; 55(7):879-84. PubMed ID: 16784958
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM.
    Panminerva Med; 2005 Dec 01; 47(4):201-10. PubMed ID: 16489319
    [Abstract] [Full Text] [Related]

  • 30. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
    Rizzo M, Berneis K, Altinova AE, Toruner FB, Akturk M, Ayvaz G, Rini GB, Spinas GA, Arslan M.
    Diabet Med; 2008 Dec 01; 25(12):1406-11. PubMed ID: 19046238
    [Abstract] [Full Text] [Related]

  • 31. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C, German Diabetes and Dialysis Study Investigators.
    Am J Kidney Dis; 2009 Nov 01; 54(5):902-11. PubMed ID: 19781835
    [Abstract] [Full Text] [Related]

  • 32. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct 01; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 33. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women.
    Halverstadt A, Phares DA, Wilund KR, Goldberg AP, Hagberg JM.
    Metabolism; 2007 Apr 01; 56(4):444-50. PubMed ID: 17378998
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study.
    Cotter J, Oliveira P, Cunha P, Polónia J.
    Nephron Clin Pract; 2009 Apr 01; 113(1):c8-15. PubMed ID: 19590230
    [Abstract] [Full Text] [Related]

  • 35. The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
    Sarafidis PA, Lasaridis AN, Nilsson PM, Mouslech TF, Hitoglou-Makedou AD, Stafylas PC, Kazakos KA, Yovos JG, Tourkantonis AA.
    Metabolism; 2005 Sep 01; 54(9):1236-42. PubMed ID: 16125536
    [Abstract] [Full Text] [Related]

  • 36. Effect of weight loss resulting from a combined low-fat diet/exercise regimen on low-density lipoprotein particle size and distribution in obese women.
    Varady KA, Lamarche B, Santosa S, Demonty I, Charest A, Jones PJ.
    Metabolism; 2006 Oct 01; 55(10):1302-7. PubMed ID: 16979399
    [Abstract] [Full Text] [Related]

  • 37. Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.
    Paniagua JA, López-Miranda J, Pérez-Martínez P, Marín C, Vida JM, Fuentes F, Fernández de la Puebla RA, Pérez-Jiménez F.
    Diabet Med; 2005 Dec 01; 22(12):1647-56. PubMed ID: 16401307
    [Abstract] [Full Text] [Related]

  • 38. Apolipoprotein H is increased in type 2 diabetic patients with microalbuminuria.
    Cavallo Perin P, Gruden G, Giunti S, Arnaldi L, Cassader M, Gambino R, Pagano G.
    Nutr Metab Cardiovasc Dis; 2000 Dec 01; 10(6):311-4. PubMed ID: 11302005
    [Abstract] [Full Text] [Related]

  • 39. Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial.
    Diepeveen SH, Verhoeven GW, Van Der Palen J, Dikkeschei LD, Van Tits LJ, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF.
    J Intern Med; 2005 May 01; 257(5):438-45. PubMed ID: 15836660
    [Abstract] [Full Text] [Related]

  • 40. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.
    Kim HJ, Ahn CW, Kang ES, Myoung SM, Cha BS, Won YJ, Lim SK, Kim KR, Huh KB, Lee HC.
    J Diabetes Complications; 2007 May 01; 21(1):7-12. PubMed ID: 17189868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.